189 related articles for article (PubMed ID: 34322374)
1. Pan-Cancer Prognostic Role and Targeting Potential of the Estrogen-Progesterone Axis.
Shen YT; Huang X; Zhang G; Jiang B; Li CJ; Wu ZS
Front Oncol; 2021; 11():636365. PubMed ID: 34322374
[TBL] [Abstract][Full Text] [Related]
2. Feasibility and predictability of perioperative PET and estrogen receptor ligand in patients with invasive breast cancer.
Gemignani ML; Patil S; Seshan VE; Sampson M; Humm JL; Lewis JS; Brogi E; Larson SM; Morrow M; Pandit-Taskar N
J Nucl Med; 2013 Oct; 54(10):1697-702. PubMed ID: 23970364
[TBL] [Abstract][Full Text] [Related]
3. Aberrant DNA methylation suppresses expression of estrogen receptor 1 (ESR1) in ovarian endometrioma.
Maekawa R; Mihara Y; Sato S; Okada M; Tamura I; Shinagawa M; Shirafuta Y; Takagi H; Taketani T; Tamura H; Sugino N
J Ovarian Res; 2019 Feb; 12(1):14. PubMed ID: 30728052
[TBL] [Abstract][Full Text] [Related]
4. ESR1 and PGR polymorphisms are associated with estrogen and progesterone receptor expression in breast tumors.
Hertz DL; Henry NL; Kidwell KM; Thomas D; Goddard A; Azzouz F; Speth K; Li L; Banerjee M; Thibert JN; Kleer CG; Stearns V; Hayes DF; Skaar TC; Rae JM
Physiol Genomics; 2016 Sep; 48(9):688-98. PubMed ID: 27542969
[TBL] [Abstract][Full Text] [Related]
5. Improved Risk Stratification for Breast Cancer Samples Based on the Expression Ratio of the Estrogen and Progesterone Receptor.
Bendrat K; Fritz P; Müller S; Brockmöller S; Debus A; Friedrichs K; Lindner C; Brinkmann F; Heidemann E; Niendorf A
Anticancer Res; 2016 Aug; 36(8):3855-63. PubMed ID: 27466487
[TBL] [Abstract][Full Text] [Related]
6. The expression and activation of sex steroid receptors in the preeclamptic placenta.
Park MN; Park KH; Lee JE; Shin YY; An SM; Kang SS; Cho WS; An BS; Kim SC
Int J Mol Med; 2018 May; 41(5):2943-2951. PubMed ID: 29436602
[TBL] [Abstract][Full Text] [Related]
7. Estrogen receptor 1 and progesterone receptor are distinct biomarkers and prognostic factors in estrogen receptor-positive breast cancer: Evidence from a bioinformatic analysis.
Wu JR; Zhao Y; Zhou XP; Qin X
Biomed Pharmacother; 2020 Jan; 121():109647. PubMed ID: 31733575
[TBL] [Abstract][Full Text] [Related]
8. Endometriosis and nuclear receptors.
Yilmaz BD; Bulun SE
Hum Reprod Update; 2019 Jul; 25(4):473-485. PubMed ID: 30809650
[TBL] [Abstract][Full Text] [Related]
9. Association of estrogen receptor and progesterone receptor genetic polymorphisms with recurrent pregnancy loss: A systematic review and meta-analysis.
Huang X; Yin T; Song M; Pan J
Eur J Obstet Gynecol Reprod Biol; 2024 May; 296():65-75. PubMed ID: 38402782
[TBL] [Abstract][Full Text] [Related]
10. The effect of elevated progesterone and pregnancy status on mRNA expression and localisation of progesterone and oestrogen receptors in the bovine uterus.
Okumu LA; Forde N; Fahey AG; Fitzpatrick E; Roche JF; Crowe MA; Lonergan P
Reproduction; 2010 Jul; 140(1):143-53. PubMed ID: 20403910
[TBL] [Abstract][Full Text] [Related]
11. High gene expression of estrogen and progesterone receptors is associated with decreased t cell infiltration in patients with NSCLC.
Oh MS; Anker JF; Chae YK
Cancer Treat Res Commun; 2021; 27():100317. PubMed ID: 33711637
[TBL] [Abstract][Full Text] [Related]
12. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G
Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363
[TBL] [Abstract][Full Text] [Related]
13. DNMT3A/3B overexpression might be correlated with poor patient survival, hypermethylation and low expression of ESR1/PGR in endometrioid carcinoma: an analysis of The Cancer Genome Atlas.
He D; Wang X; Zhang Y; Zhao J; Han R; Dong Y
Chin Med J (Engl); 2019 Jan; 132(2):161-170. PubMed ID: 30614867
[TBL] [Abstract][Full Text] [Related]
14. Expression and prognostic significance of estrogen and progesterone receptors in adenocarcinoma of the uterine cervix. An immunocytochemical study.
Masood S; Rhatigan RM; Wilkinson EW; Barwick KW; Wilson WJ
Cancer; 1993 Jul; 72(2):511-8. PubMed ID: 8319181
[TBL] [Abstract][Full Text] [Related]
15. Actions of methyl-, propyl- and butylparaben on estrogen receptor-α and -β and the progesterone receptor in MCF-7 cancer cells and non-cancerous MCF-10A cells.
Wróbel AM; Gregoraszczuk EŁ
Toxicol Lett; 2014 Nov; 230(3):375-81. PubMed ID: 25128701
[TBL] [Abstract][Full Text] [Related]
16. Ovarian steroids, oxytocin, and tumor necrosis factor modulate equine oviduct function.
Pinto-Bravo P; Galvão A; Rebordão MR; Amaral A; Ramilo D; Silva E; Szóstek-Mioduchowska A; Alexandre-Pires G; Roberto da Costa R; Skarzynski DJ; Ferreira-Dias G
Domest Anim Endocrinol; 2017 Oct; 61():84-99. PubMed ID: 28753494
[TBL] [Abstract][Full Text] [Related]
17. ESR1 and PGR gene promoter methylation and correlations with estrogen and progesterone receptors in ductal and lobular breast cancer.
Medina-Jaime AD; Reyes-Vargas F; Martinez-Gaytan V; Zambrano-Galvan G; Portillo-Delcampo E; Burciaga-Nava JA; Reyes-Romero M; Sifuentes-Alvarez A
Asian Pac J Cancer Prev; 2014; 15(7):3041-4. PubMed ID: 24815444
[TBL] [Abstract][Full Text] [Related]
18. The validation of estrogen receptor 1 mRNA expression as a predictor of outcome in patients with metastatic non-small cell lung cancer.
Atmaca A; Al-Batran SE; Wirtz RM; Werner D; Zirlik S; Wiest G; Eschbach C; Claas S; Hartmann A; Ficker JH; Jäger E; Brueckl WM
Int J Cancer; 2014 May; 134(10):2314-21. PubMed ID: 24174373
[TBL] [Abstract][Full Text] [Related]
19. DNA methylation patterns of steroid receptor genes ESR1, ESR2 and PGR in deep endometriosis compromising the rectum.
Meyer JL; Zimbardi D; Podgaec S; Amorim RL; Abrão MS; Rainho CA
Int J Mol Med; 2014 Apr; 33(4):897-904. PubMed ID: 24481237
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical determination of estrogen and progesterone receptors in breast cancer: relationship with clinicopathologic factors in 302 patients in Ivory Coast.
Effi AB; Aman NA; Koui BS; Koffi KD; Traoré ZC; Kouyate M
BMC Cancer; 2017 Feb; 17(1):115. PubMed ID: 28173783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
